Grab your lunch and join Professor Siebrasse as he discusses some hot topics in patent law. Topics will include the Federal Court of Appeal’s decision in Nova Chemicals Corporation v Dow Chemicals Company, 2020 FCA 141 and its many implications for damages and accounting of profits and the impact of the UK Supreme Court decision in Regeneron v Kymab, [2020] UKSC 27 on the Canadian law of infringement and overbreadth.
Norman Siebrasse is a Professor of Law at the University of New Brunswick. His research focuses on patent law, particularly pharmaceutical patent law, patent remedies, and the intersection of intellectual property law and commercial law. His blog, Sufficient Description, comments on recent Canadian patent law cases. His writing, including his blog, is regularly judicially cited.
